Xgeva (denosumab)

pCPA File Number: 20775
Negotiation Status:
Negotiations were not pursued
Indication(s):
Prevention of skeletal-related events due to bone metastases from breast cancer
Sponsor/Manufacturer:
Amgen Canada Inc.
CDA-AMC Project Number:
SR0433-000
pCPA Engagement Letter Issued:
Not Applicable
Negotiation Process Concluded: